BSE filing, BSE: 543916. Summary written from the filing by ALFA Finder's alert engine.
Hemant Surgical Industries Ltd: key numbers
- Share price
- ₹572.55
- Market cap
- ₹746.5 Cr
- Revenue (annual)
- ₹231.8 Cr
- Net profit (annual)
- ₹18.19 Cr
- P/E (TTM)
- 41.0×Sector 52.0×
- Promoter holding
- 52.83%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hemant Surgical Industries Ltd
All →Hemant Surgical Industries Other Announcement
Hemant Surgical Industries Ltd filed its quarterly shareholding pattern statement for the period ended September 30, 2026, as required under SEBI regulations.
Hemant Surgical Industries Annual General Meeting
Hemant Surgical Industries Ltd. conducted its 37th Annual General Meeting on September 29, 2026. Shareholders adopted financial statements and ratified the Cost Auditor's remuneration.
Hemant Surgical Industries Other Announcement
The company informs the exchange that it has sent letters to shareholders with unregistered email addresses, providing a weblink for the AGM Notice and Integrated Annual Report.
Hemant Surgical Industries Annual Report
Hemant Surgical Industries Ltd has filed its Integrated Annual Report and Notice of the 37th Annual General Meeting for the financial year 2025-26.
Hemant Surgical Industries Annual General Meeting
Hemant Surgical Industries Ltd has scheduled its 37th Annual General Meeting for September 29, 2026, to be conducted through video conferencing.
Hemant Surgical Industries Announces New Order Win
Hemant Surgical Industries signed a manufacturing agreement with Sonomed Escalon, USA for ophthalmic ultrasound devices. The deal establishes local SKD manufacturing and exclusive distribution rights within India.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.